UK markets closed

Sanofi (0A2V.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
49.560.00 (0.00%)
At close: 07:00PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.41
52-week change 339.32%
S&P500 52-week change 318.96%
52-week high 357.78
52-week low 337.81
50-day moving average 353.56
200-day moving average 351.37

Share statistics

Avg vol (3-month) 320.43k
Avg vol (10-day) 3123.39k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 81.1B
% held by insiders 10.00%
% held by institutions 110.52%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 33.76
Trailing annual dividend yield 37.59%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 Jun 2024

Profitability

Profit margin 8.95%
Operating margin (ttm)14.11%

Management effectiveness

Return on assets (ttm)4.15%
Return on equity (ttm)5.82%

Income statement

Revenue (ttm)47.08B
Revenue per share (ttm)18.81
Quarterly revenue growth (yoy)7.50%
Gross profit (ttm)N/A
EBITDA 10.96B
Net income avi to common (ttm)4.22B
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)-22.40%

Balance sheet

Total cash (mrq)6.79B
Total cash per share (mrq)5.43
Total debt (mrq)23.75B
Total debt/equity (mrq)32.54%
Current ratio (mrq)1.00
Book value per share (mrq)58.10

Cash flow statement

Operating cash flow (ttm)8.12B
Levered free cash flow (ttm)3.81B